Tuesday, April 21, 2026

1:00 PM - 2:00 PM Eastern Daylight Time
12:00 PM – 1:00 PM Central Daylight Time
11:00 AM – 12:00 PM Mountain Daylight Time
10:00 AM – 11:00 AM Pacific Daylight Time/Mountain Standard Time

FACULTY

	Petrice M. Cogswell, MD, PhD Associate Professor Mayo Clinic Rochester, Minnesota
	Sharon A. Brangman, MD Distinguished Service Professor Chair, Department of Geriatrics Director, Upstate Center of Excellence for Alzheimer's Disease Upstate Medical University Syracuse, New York

PROGRAM OVERVIEW

This virtual summit brings together leading experts across multiple disciplines to advance practical knowledge in recognizing, monitoring, and managing amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease receiving anti-amyloid therapies (AATs). Through case-based discussion, evidence-driven updates, and multidisciplinary perspectives, the program focuses on improving confidence in ARIA identification, optimizing collaborative workflows across care settings, and strengthening patient-centered communication and shared decision-making to support safe and effective treatment.

TARGET AUDIENCE

This activity is tailored to meet the educational needs of neurologists, psychiatrists – including geriatric psychiatrists, radiologists, neuroradiologists, primary care physicians, emergency physicians, and infusion/triage nurses.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Summarize the pathophysiology, clinical presentation, and classification of ARIA (including ARIA-E and ARIA-H) in patients receiving AATs for AD
• Evaluate guidelines for ARIA monitoring based on signs, symptoms, and imaging findings in patients receiving AATs for AD
• Communicate effectively with patients and caregivers about individual ARIA risk factors, benefits of AATs, and individualized risk mitigation strategies through SDM principles
• Collaborate with multidisciplinary team members (including emergency medicine, radiology, and nursing staff) to ensure coordinated ARIA monitoring, recognition, and management across care settings for patients with AD receiving AATs

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

AAPA CREDIT DESIGNATION STATEMENT – LIVE

Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.

This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

ACCME INNOVATION PARTNER - US Learners Only

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]